Ann: Q3 FY2025 business update, page-7

It looks like the industry need's to consolidate a little more and set more appropriate standards so patients expectations around prescribing and cost are inline with the TGA rules and it makes it a viable business

Reading patients experiences online is frustrating,
They want to book in have a 20 minute online call to get scripts and then shop from a catalogue
This is obviously not what the TGA want

Then in comparison you look at the financials of Vitura, huge revenue but tight margins leading to little take home profit, yet they still call us 'Big Pharma'
Take 2024
Revenue: $123.87M
Net income: $3.51M
That's less than 3%


More competition in this space right now will lead to more 'Cowboy' companies and it takes away from the whole point of regulating medical cannabis and give patients inappropriate expectations

However like I said I do see the industry consolidating and hopefully it leads to a more responsible prescribing structure and appropriately priced medicine